Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > net house -tsx only - today
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(83)
•••
Post by 2021Gambleon Jul 14, 2021 2:54pm
165 Views
Post# 33543483

net house -tsx only - today

net house -tsx only - today can never get the formatting right, but here is today...

FIDELITY +107,000 SHARES

Broker    Broker Name    Buy Average    Buy Volume    Sell Average    Sell Volume
001    Anonymous    0.411    20000    0.416    153500
002    RBC Capital Markets    0.427    17500    0.435    29500
005    null    0.436    500    0.436    500
007    TD Securities Inc.    0.415    57500    0.420    112000
009    BMO Nesbitt Burns Inc.    0.412    12500    0.407    67000
013    Instinet Canada Ltd.    0.410    1000    0.000    0
019    Desjardins Securities Inc.    0.000    0    0.420    33500
022    Fidelity Clearing Canada ULC    0.425    107000    0.000    0
033    Canaccord Genuity Corp.    0.412    15500    0.424    8000
079    CIBC World Markets  Inc.    0.406    111000    0.427    26000
080    National Bank Financial Inc.    0.428    91500    0.428    7500
085    Scotia Capital Inc.    0.000    0    0.430    500
124    Questrade Inc.    0.431    4000    0.000    0


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities